Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canton Biologics is a private China-based biologics CDMO focused on development and manufacturing services for large-molecule therapeutics. The company provides integrated CMC support spanning molecular design optimization, cell line development, upstream and downstream process development, analytical and formulation development, IND-enabling support, clinical batch supply, and commercial GMP manufacturing. Its service focus includes monoclonal antibodies, bispecific antibodies, fusion proteins, and recombinant proteins for Chinese and global biotech clients. The broader group also includes a Hong Kong innovation subsidiary developing early-stage regenerative and aesthetic biologics programs, but the core Canton Biologics business is a service-oriented biologics manufacturing platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canton Biologics.